Molecular and clinical characterization of TIM-3 in glioma through 1,024 samples

Background: Researches on immunotherapy of glioma has been increasing exponentially in recent years. However, autoimmune-like side effects of current immune checkpoint blockade hindered the clinical application of immunotherapy in glioma. The discovery of the TIM-3, a tumor-specific immune checkpoin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Li, Guanzhang, Wang, Zheng, Zhang, Chuanbao, Liu, Xing, Cai, Jinquan, Wang, Zhiliang, Hu, Huimin, Wu, Fan, Bao, Zhaoshi, Liu, Yanwei, Zhao, Liang, Liang, Tingyu, Yang, Fan, Huang, Ruoyu, Zhang, Wei, Jiang, Tao
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5593703/
https://ncbi.nlm.nih.gov/pubmed/28919992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1328339
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados